Publication date: Aug 01, 2026
Since coronavirus disease 2019 (COVID-19) pandemic, its variants have challenged vaccine effectiveness and immunity, particularly among high-risk individuals. Assessment of the risk of severe COVID-19 in these populations is crucial for informed therapeutic decisions. We aim to correlate early quantitative SARS-CoV-2 spike antibody (S ab) levels in SARS-CoV-2 infections with the risk of severe COVID-19. We conducted a retrospective cohort study of hospitalized patients with early-stage COVID-19 and S ab titers between April 2021 and June 2022. S ab titers were stratified into four categories:
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Long Covid |
Original Article
(Visited 2 times, 1 visits today)